2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society
Document Type
Journal Article
Publication Date
8-1-2019
Journal
Heart Rhythm
Volume
16
Issue
8
DOI
10.1016/j.hrthm.2019.01.024
Keywords
ACC/AHA Clinical Practice Guidelines; Acute coronary syndrome; Anticoagulants; Anticoagulation agents; Antiplatelet agents; Apixaban; Atrial fibrillation; Atrial flutter; Cardioversion; Coronary artery disease; Coronary heart disease; Dabigatran; Edoxaban; Focused update; Hypertension; Idarucizumab; Myocardial infarction; Obesity; Percutaneous coronary intervention; Risk factors; Rivaroxaban; Sleep apnea; Stents; Stroke; Thromboembolism; Warfarin
APA Citation
January, C., Wann, L., Calkins, H., Chen, L., Cigarroa, J., Cleveland, J., Ellinor, P., Ezekowitz, M., Field, M., Furie, K., Heidenreich, P., Murray, K., Shea, J., Tracy, C., & Yancy, C. (2019). 2019 AHA/ACC/HRS focused update of the 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. Heart Rhythm, 16 (8). http://dx.doi.org/10.1016/j.hrthm.2019.01.024